George M. Martin

George M. Martin (June 30, 1927 – December 17, 2022) was an American biogerontologist. He was a faculty member at the University of Washington from 1957 until the end of his career. Martin was a professor emeritus in the Department of Pathology, adjunct professor of genome sciences, and director emeritus of the University of Washington's Alzheimer's Disease Research Center.

Martin is best known as one of the founders of modern biogerontology. Martin attended less than a year at the Cooper Union School of Engineering, and one year at the College of the City of New York before serving in the US Navy from 1945 to 1946. He moved to Alaska at age 19, and held various jobs including playing trumpet in a jazz band and working for a railroad company. After two years at the University of Alaska Fairbanks, Martin completed his undergraduate degree in chemistry at the University of Washington in 1949 before completing his medical doctorate from the same institution in 1952. where he founded the Clinical Cytogenetics Laboratory. This work served as a catalyst for Martin to learn about genetics, as supported by Arno Motulsky, founder of the University of Washington department of Medical Genetics. including describing donor covariates that contributed to replicative limits in culture.

Martin's major research focus involved using genetic approaches to elucidate the pathobiology of aging and age-related diseases. Martin's work provided important insights into multiple topics in the field of geroscience. His group conducted genetic linking studies identifying loci associated with familial forms of Alzheimer's disease, a discovery that led to the recognition of amyloid beta (Aβ) in the pathology of that disorder. and its underlying contributory mechanisms to the disorder. His studies provided the first evidence that epithelial cells from arteries, especially from parts that develop severe atherosclerosis, have limited potential to divide. He and colleagues demonstrated that senescent cells cannot be returned to a replicative state when their cytoplasm is combined with cytoplasm from normal, young cells. Martin's laboratory was the first to demonstrate the accumulation of somatic mutations in human epithelial cells during the aging process. His later research used genetic engineering in mice to elucidate mechanisms of aging and Alzheimer's disease.

Martin was not as well known as a futurist, but some of Martin's ideas predate predictions of better known futurists such as Ray Kurzweil and Vernor Vinge, and are similar to those eventually championed in the field. In 1971, for example, Martin described a process for achieving a condition equatable to immortality using a scientific process now termed mind uploading:

Honors

Source: National Institutes of Health Merit Award, 1989 Allied Signal Achievement Award in Aging, 1990 National Academy of Medicine, American Federation for Aging Research Irving S. Wright award, 1996 Fondation IPSEN Longevity prize, 2002 American Aging Association Distinguished Scientist Award, 2004 Shober Prize, Martin-Luther University Halle-Wittenberg, 2005 Trustee Emeritus, Buck Institute for Age Research, 2006 Honorary Alumnus (NIMH-sponsored Summer Research Institute in Geriatric Psychiatry), 2008 Dart/New York University Biotechnology Achievement Award, 2011 SENECA Medal for Research into Aging, Industrial Club of Düsseldorf, Düsseldorf, Germany, 2011 Inaugural Science Award of the Buck Institute for Research in Aging, 2011